NF-κB inhibitors significantly attenuate the transcription of high affinity type-2 cationic amino acid transporter in LPS-stimulated rat kidney

Acta Anaesthesiologica Taiwanica

Volumn 43, Issue 1, 2005, Pages 23-32

  Chu, Li Chuan ^a   Tsai, Pei Shan ^b   Lee, Jie Jen ^a   Yen, Chia Hsiang ^a   Huang, Chun Jen ^a,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c Mackay Medicine   (Taiwan)

Author keywords

CAT 2; iNOS; Kidney; NF B; Nitric oxide; Rat; Sepsis

Indexed keywords

AMINO ACID TRANSPORTER; DEXAMETHASONE; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PYRROLIDINE DITHIOCARBAMATE; SALICYLATE SODIUM; SODIUM CHLORIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENDOTOXEMIA; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; KIDNEY INJURY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HEART RATE; KIDNEY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; UREA NITROGEN BLOOD LEVEL;

ANIMALS; BLOOD PRESSURE; BLOOD UREA NITROGEN; CATIONIC AMINO ACID TRANSPORTER 2; HEART RATE; KIDNEY; LIPOPOLYSACCHARIDES; MALE; NF-KAPPA B; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 16844381008     PISSN: 02541319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Thiemermann C, Ruetten H, Wu CC, Vane JR: The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116:2845-2851, 1995.
2. Schwartz D, Blantz RC: Nitric oxide, sepsis, and the kidney. Semin Nephrol 19:272-276, 1999.
3. Schwartz D, Mendonca M, Schwartz I, Xia Y, Satriano J, Wilson CB, Blantz RC: Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 100:439-448, 1997.
4. Satriano J, Schwartz D, Ishizuka S, Lortie MJ, Thomson SC, Gabbai F, Kelly CJ, Blantz RC: Suppression of inducible nitric oxide generation by agmatine aldehyde: beneficial effects in sepsis. J Cell Physiol 188:313-320, 2001.
5. Baydoun AR, Wileman SM, Wheeler-Jones CP, Marber MS, Mann GE, Pearson JD, Closs EI: Transmembrane signalling mechanisms regulating expression of cationic amino acid transporters and inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem J 344 (Pt 1):265-272, 1999.
6. Nicholson B, Manner CK, Kleeman J, MacLeod CL: Sustained nitric oxide production in macrophages requires the arginine transporter CAT2. J Biol Chem 276:15881-15885, 2001.
7. Hattori Y, Kasai K, Gross SS: Cationic amino acid transporter gene expression in cultured vascular smooth muscle cells and in rats. Am J Physiol 276: H2020-H2028, 1999.
8. Stevens BR, Kakuda DK, Yu K, Waters M, Vo CB, Raizada MK: Induced nitric oxide synthesis is dependent on induced alternatively spliced CAT-2 encoding L-arginine transport in brain astrocytes. J Biol Chem 271:24017-24022, 1996.
9. Yang S, Huang CJ, Tsai PS, Cheng CR, Stevens BR, Skimming JW: Renal transcription of high-affinity type-2 cationic amino acid transporter is up-regulated in LPS-stimulated rodents. Acta Anaesthesiol Scand 48:308-316, 2004.
10. Schwartz D, Schwartz IF, Gnessin E, Wollman Y, Chernichovsky T, Blum M, Iaina A: Differential regulation of glomerular arginine transporters (CAT-1 and CAT-2) in lipopolysaccharide-treated rats. Am J Physiol Renal Physiol 284: F788-F795, 2003.
11. Kakuda DK, Sweet MJ, Mac Leod CL, Hume DA, Markovich D: CAT2-mediated L-arginine transport and nitric oxide production in activated macrophages. Biochem J 340 (Pt 2):549-553, 1999.
12. Huang CJ, Stevens BR, Nielsen RB, Slovin PN, Fang X, Nelson DR, Skimming JW: interleukin-10 inhibition of nitric oxide biosynthesis involves suppression of CAT-2 transcription. Nitric Oxide 6:79-84, 2002.
13. Blackwell TS, Christman JW: The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 17:3-9, 1997.
14. Hammermann R, Dreissig MD, Mossner J, Fuhrmann M, Berrino L, Gothert M, Racke K: Nuclear factor-kappa B mediates simultaneous induction of inducible nitric-oxide synthase and up-regulation of the cationic amino acid transporter CAT-2B in rat alveolar macrophages. Mol Pharmacol 58:1294-1302, 2000.
15. Huang CJ, Tsai PS, Lu YT, Cheng CR, Stevens BR, Skimming JW, Pan WH: NF-kappa B involvement in the induction of high affinity CAT-2 in lipopolysaccharide-stimulated rat lungs. Acta Anaesthesiol Scand 48:992-1002, 2004.
16. Hung YC, Tsai PS, Huang CJ, Yang S, Skimming JW, Hsieh MC: Change in expression of the guanosine triphosphate cyclohydrolase I in LPS-stimulated rats is tissue specific. Acta Anaesthesiol Taiwan 42:23-31, 2004.
17. Remick DG, Newcomb DE, Bolgos GL, Call DR: Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13:110-116, 2000.
18. Liu SF, Ye X, Malik AB: In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol 159:3976-3983, 1997.
19. Skimming JW, Nasiroglu O, Huang CJ, Wood CE, Stevens BR, Haque IU, Scumpia PO, Sarcia PJ: Dexamethasone suppresses iNOS yet induces GTPCH and CAT-2 mRNA expression in rat lungs. Am J Physiol Lung Cell Mol Physiol 285:L484-L491, 2003.
20. Kopp E, Ghosh S: Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265:956-959, 1994.
21. Sade K, Schwartz D, Wolman Y, Schwartz I, Chernichovski T, Blum M, Brazowski E, Keynan S, Raz I, Blantz RC, Iaina A: Time course of lipopolysaccharide-induced nitric oxide synthase mRNA expression in rat glomeruli. J Lab Clin Med 134: 471-477, 1999.
22. Schwartz IF, Schwartz D, Traskonov M, Chernichovsky T, Wollman Y, Gnessin E, Topilsky I, Levo Y, Iaina A: L-Arginine transport is augmented through up-regulation of tubular CAT-2 mRNA in ischemic acute renal failure in rats. Kidney Int 62:1700-1706, 2002.
23. Hattori Y, Kasai K, Gross SS: Cationic amino acid transporter gene expression in cultured vascular smooth muscle cells and in rats. Am J Physiol 276:H2020-H2028, 1999.
24. Nudel U, Zakut R, Shani M, Neuman S, Levy Z, Yaffe D: The nucleotide sequence of the rat cytoplasmic beta-actin gene. Nucleic Acids Res 11:1759-1771, 1983.
25. Satriano J, Schwartz D, Ishizuka S, Lortie MJ, Thomson SC, Gabbai F, Kelly CJ, Blantz RC: Suppression of inducible nitric oxide generation by agmatine aldehyde: beneficial effects in sepsis. J Cell Physiol 188:313-320, 2001.
26. Huang CJ, Wood CE, Nasiroglu O, Slovin PN, Fang X, Skimming JW: Resuscitation of hemorrhagic shock attenuates intrapulmonary nitric oxide formation. Resuscitation 55:201-209, 2002.
27. Hierholzer C, Harbrecht B, Menezes JM, Kane J, MacMicking J, Nathan CF, Peitzman AB, Billiar TR, Tweardy DJ: Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 187: 917-928, 1998.
28. Christman JW, Lancaster LH, Blackwell TS: Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med 24: 1131-1138, 1998.